For: | Jiang C, Zhang ZH, Li JX. Current status of drug therapy for chronic hepatitis B. World J Gastroenterol 2025; 31(2): 99443 [PMID: 39811512 DOI: 10.3748/wjg.v31.i2.99443] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v31/i2/99443.htm |
Number | Citing Articles |
1 |
Shihao Zheng, Qiuyue Wang, Wenying Qi, Jinchi Xie, Xiaobin Zao, Xiaoke Li, Peng Zhang, Yongan Ye. The Role of Chinese Medicine in the Treatment of Chronic Hepatitis B. The American Journal of Chinese Medicine 2025; 53(05): 1285 doi: 10.1142/S0192415X25500508
|
2 |
Soe Thiha Maung, Roongruedee Chaiteerakij. Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B. Journal of Viral Hepatitis 2025; 32(7) doi: 10.1111/jvh.70040
|
3 |
Lan-Lan Si, Zhen-Ping Fan, Wen-Hui Liu, Rong-Juan Chen, Xue-Yuan Chen, Dong Ji, Le Li, Chun Chen, Hao Liao, Jun Wang, Dong-Ping Xu, Jun Zhao, Yan Liu. Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients. World Journal of Hepatology 2025; 17(8): 107456 doi: 10.4254/wjh.v17.i8.107456
Abstract(93) |
Core Tip(85) |
Full Article(HTML)(219)
|
Full Article with Cover (PDF)-4586K(23)
|
Audio-1570K(5)
|
Peer-Review Report-249K(13)
|
Answering Reviewers-502K(10)
|
Supplementary Material-131K(12)
|
Full Article (PDF)-4293K(18)
|
Full Article (XML)-116K(15)
|
Times Cited (0)
|
Total Visits (1044)
|
Open
|